NetraMark Holdings Inc C.AIAI

Alternate Symbol(s): AINMF

Healthcare Medical Devices

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by culturedpiggy01on Mar 09, 2022 2:53pm

269 Views

Post# 34500464

$MEND 's CSO &Director of Bioinformatics receive award

MEND.c ‘s CSO Dr. Joseph Geraci and Director of Bioinformatics, Mike Tsay alongside PhD student Bessi Qorri, Abhishek Agrawal, & Dr. Rhoda Au have received the 'Highly Cited Paper' award from the peer-reviewed journal, Exploration of Medicine https://ca.finance.yahoo.com/news/nurosenes-cso-director-bioinformatics-receives-153800849.html

Their research validates $MEND ‘s AI platform and provides novel insights into Alzheimer's disease (AD, the diagnostics and therapeutics market value of which is estimated at USD $7 Billion. A recognition like this from peers is truly validating, and promotes my faith in the company for sure. congrats to the team!

td, $MEND.c trading at $0.64 with market cap at $25.78 M

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”